Targeted Therapies in Veterinary Medicine: Accounting for Genetic, Environmental, and Individual Animal Variability
Applied Animal Science Bulletin · 29.03.2026 · 29-40
DOI: 10.22194/aasb/25.10201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Animal Science Bulletin, online erschienen am 29.03.2026. Verfasst von Atia Shahnaz und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Targeted therapies represent a major paradigm shift in veterinary medicine, moving clinical decision-making away from generalized treatment protocols toward individualized, evidence-driven interventions. This review evaluates the scientific foundations, technological drivers, and multispecies applications of targeted veterinary therapy by examining how genetic heterogeneity, environmental exposures, and individual physiological differences shape therapeutic responses. Recent advances in genomic sequencing, pharmacogenomics, molecular diagnostics, and bioinformatics have enabled the identification of clinically relevant variants such as MDR1/ABCB1 mutations in dogs and cardiomyopathy-associated alleles in cats that directly influence drug selection, dosing, and safety. Parallel developments in artificial intelligence, predictive modeling, big-data analytics, and wearable sensor systems have created new opportunities for continuous monitoring, early diagnosis, and dynamic therapeutic adjustment across companion animals, livestock, equines, and wildlife. Despite these advances, significant limitations persist. Access to sequencing tools and validated biomarkers remains uneven; species-specific genomic resources are incomplete; economic constraints limit uptake, particularly in production systems; and ethical issues concerning genetic data ownership, privacy, and responsible use require thoughtful regulation. The risk of misinterpretation especially when biomarkers are applied without sufficient validation underscores the need for standardized frameworks and interdisciplinary clinical oversight. Looking forward, the integration of routine genomics into everyday practice, One-Health– aligned therapeutic strategies, precision breeding approaches, and globally harmonized data-sharing infrastructures will be essential for translating technological potential into equitable and effective veterinary care. Targeted therapy has the capacity to substantially improve treatment precision, reduce adverse outcomes, and enhance animal welfare, provided its implementation remains scientifically rigorous and ethically grounded. Keywords: Targeted veterinary therapy, precision medicine, pharmacogenomics, genomic sequencing, MDR1 mutation, biomarkers and artificial intelligence.
Zitieren
APA
Shahnaz, A., & Rehan, M. (2026). Targeted Therapies in Veterinary Medicine: Accounting for Genetic, Environmental, and Individual Animal Variability. Applied Animal Science Bulletin, 29-40. https://doi.org/10.22194/aasb/25.10201
Vancouver
Shahnaz A, Rehan M. Targeted Therapies in Veterinary Medicine: Accounting for Genetic, Environmental, and Individual Animal Variability. Applied Animal Science Bulletin. 2026:29-40. doi:10.22194/aasb/25.10201
BibTeX
@article{Shahnaz2026,
author = {Shahnaz, Atia and Rehan, Muhammad},
title = {Targeted Therapies in Veterinary Medicine: Accounting for Genetic, Environmental, and Individual Animal Variability},
journal = {Applied Animal Science Bulletin},
year = {2026},
pages = {29--40},
doi = {10.22194/aasb/25.10201}
}
EUVIMED